Author Archives: Paul Older

Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy.

C. McHugh, Massachusetts General Hospital,  Boston, MA 02114, USA.
S. K. Gustus, B. J. Petek, M. W. Schoenike, K. S. Boyd, J. B. Kennett, et al.

Eur J Prev Cardiol 2025

AIMS: Cardiopulmonary exercise testing (CPET) is often used when athletes present with suspected hypertrophic cardiomyopathy (HCM). While low peak oxygen consumption (pV O2) augments concern for HCM, athletes with HCM frequently display supranormal pV O2, which limits this parameter’s diagnostic utility. We aimed to compare other CPET parameters in healthy athletes and equally fit individuals with HCM.
METHODS AND RESULTS: Using cycle ergometer CPETs from a single centre, we compared ventilatory efficiency and recovery kinetics between individuals with HCM [percent predicted pV O2(ppV O2) > 80%, non-obstructive, no nodal agents] and healthy athletes, matched (2:1 ratio) for age, sex, height, weight and ppV O2. Consistent with matching, HCM (n = 30, 43.6 +/- 14.2 years) and athlete (n = 60, 43.8 +/- 14.9 years) groups had similar, supranormal pV O2 (39.5 +/- 9.1 vs. 41.1 +/- 9.1 mL/kg/min, 125 +/- 26 vs. 124 +/- 25% predicted). Recovery kinetics were also similar. However, HCM participants had worse ventilatory efficiency, including higher early V E/V CO2 slope (25.4 +/- 4.7 vs. 23.4 +/- 3.1, P = 0.02), higher V E/V CO2 nadir (27.3 +/- 4.0 vs. 25.2 +/- 2.6, P = 0.004) and lower end-tidal CO2 at the ventilatory threshold (42.9 +/- 6.4 vs. 45.7 +/- 4.8 mmHg, P = 0.02). HCM participants were more likely to have abnormally high V E/V CO2 nadir (>30) than athletes (20 vs. 3%, P = 0.02).
CONCLUSION: Even in the setting of similar and supranormal pV O2, ventilatory efficiency is worse in HCM participants vs. healthy athletes. Our results demonstrate the utility of CPET beyond pV O2 assessment in ‘grey zone’ athlete cases in which the diagnosis of HCM is being debated.
We sought to examine exercise test findings in healthy athletes and equally fit individuals with a form of heart enlargement that commonly gets confused with ‘athlete’s heart’ called hypertrophic cardiomyopathy (HCM) to see if elements of the exercise test could distinguish between these two groups. This is relevant as fit individuals often present for exercise testing as part of the work up to see if they have HCM or not, and getting the answer right is important because HCM is amongst the most common causes of sudden cardiac death in athletes.By design, individuals with HCM in this study were equally fit as the athletes, with both groups having fitness levels (‘VO2 max’ levels) around 25% higher than expected for individuals of similar age and sex.Despite this similar and supranormal fitness, individuals with HCM had worse ventilatory efficiency than athletes. This is a metric that reflects how well the heart and lungs work together to get rid of the waste gas carbon dioxide during exercise. This finding should focus more attention on this parameter when exercise tests are being performed to evaluate for HCM in clinical practice.

Cardiopulmonary Exercise Testing

Tiffany L. Brazile, M.D., Benjamin D. Levine, M.D., and Keri M. Shafer, M.D.

NEJM Evid 2025;4(2)
DOI: 10.1056
Because symptoms of cardiopulmonary disease often occur with exertion, cardiopulmonary exercise testing (CPET) has a unique role in the assessment of patient symptoms, disease severity, prognosis, and response to therapy. In addition to the evaluation of cardiovascular and pulmonary physiology, CPET provides an assessment of the interaction of the cardiovascular and pulmonary systems with the musculoskeletal, nervous, and hematological systems. In this article, we review key CPET variables, protocols, and clinical indications.

Just a reminder about the Basel Practicum on CPET Sept 3rd to 5th 2025

A great time to renew old friends and catch up with the latest in CPET

27th European Practicum on Clinical Exercise Testing

https://conferences.unibas.ch/frontend/index.php?sub=122

Join us in Basel for the 27th European Practicum on Clinical Exercise Testing (September 3rd to 5th, 2025), a premier event for sport and exercise medicine physicians.
This three-day course offers a unique opportunity to engage with internationally recognized experts in cardiopulmonary exercise testing (CPET).
Our program features high-quality lectures, hands-on tutorials, and interactive small-group sessions tailored to all experience levels.
Topics span from foundational CPET physiology to advanced clinical applications across a range of health and disease states.
Hosted at the University of Basel’s Department of Sport, Exercise and Health, the CPX Practicum 2025 is your gateway to the latest in exercise testing science and clinical integration.

Just be there

My regards

Professor Arno Schmidt-Trucksäss & Dr Paul Older

Unveiling the limitations of non-metabolic thresholds in assessing maximal effort: The role of cardiopulmonary exercise testing.

Baracchini, Nikita; Cardiothoracovascular Department,  ASUGI, University of Trieste, Italy.
Capovilla, Teresa Maria; Rossi, Maddalena; Carriere, Cosimo; et al

International journal of cardiology,2025 Apr 20

  • Introduction: Maximal effort, defined by a respiratory exchange ratio (RER) ≥ 1.10, is crucial for accurate interpretation of cardiopulmonary exercise testing (CPET). Standard tests rely on non-metabolic thresholds, such as peak predicted heart rate (ppHR) ≥ 85 %, double product (DP) ≥ 20,000 bpm*mmHg and peak metabolic equivalent of task (MET) ≥ 5.0. This study aimed to assess the effectiveness of non-metabolic thresholds in detecting maximal effort, compared with the RER ≥ 1.10 criterion.
  • Methods: We retrospectively analyzed stable patients who underwent CPET from 2022 to 2023, regardless of test indication, history of heart failure (HF), or medication use. All patients also performed transthoracic echocardiography.
  • Results: Among 239 middle-aged patients (53 ± 14 years, 67 % male), 86 % achieved a RER ≥ 1.10, and 65 % had a diagnosis of HF. Non-metabolic thresholds correctly identified maximal efforts (RER ≥ 1.10) in 75 % of the cases (AUC < 0.600). Misclassified cases were more likely to have a history of atrial fibrillation (AF), paced rhythm, HF, and beta-blockers or RAAS inhibitors use. These patients exhibited lower VO 2 peak and higher VE/VCO 2 slope. Multivariable analysis identified HF history (OR 4.8, CI 95 % 1.6-15.6, p: 0.005), low resting DP (≤ 7500 mmHg*bpm), and ramp protocol as independent predictors of discordant tests.
  • Conclusion: Non-metabolic thresholds misclassified up to 25 % of tests with RER ≥ 1.10 as non-maximal, potentially leading to inaccurate interpretation. In patients with HF, poor expected functional capacity and low DP, direct referral to CPET-equipped facilities may provide more accurate assessment than relying on non-metabolic thresholds.

Prehabilitation: Do We Need Metabolic Flexibility?

Tetlow, Nicholas; Centre for Peri-operative Medicine, Division of Surgery,  University College London, London, UK.;
Whittle, John

Annals of nutrition & metabolism,2025 Mar 21

  • Background: Metabolic flexibility, the capacity to switch between energy sources in response to changing physiological demands, emerges as a critical determinant of perioperative resilience. In the context of surgery, where metabolic demands are high and energy homeostasis is disrupted, patients with metabolic inflexibility may experience worse outcomes due to impaired immune responses and heightened insulin resistance, resulting in prolonged recovery times.
  • Summary: This article explores the implications of metabolic flexibility in the perioperative period and examines the potential for prehabilitation strategies, such as targeted exercise and nutritional interventions, to improve patient readiness for surgery. Cardiopulmonary exercise testing is discussed as a valuable assessment tool for metabolic flexibility, capable of providing insights into a patient’s fuel adaptability and overall metabolic health preoperatively. Evidence suggests that targeted exercise and nutritional strategies can enhance mitochondrial function, improve nutrient-sensing pathways, and increase substrate oxidation, which may reduce perioperative complications and support immune resilience.
  • Key Messages: Future research should prioritise refining methods to identify metabolically inflexible patients and tailoring prehabilitation interventions to optimise metabolic flexibility. Enhancing perioperative metabolic readiness is important for populations vulnerable to metabolic dysfunction, such as those with obesity, diabetes, and cancer. Aligning metabolic optimisation with surgical recovery demands may help establish new standards in perioperative care and improve patient outcomes.

The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy.

Mazzella, Antonio; Division of Thoracic Surgery, IEO European Institute of Oncology,  Milan, Italy.
Orlandi, Riccardo; Maisonneuve, Patrick; Uslenghi, Clarissa;

Journal of personalized medicine,2025 Mar 31

Aimshis study aims to determine whether maximal oxygen consumption (VO2max) or predicted postoperative (ppo)-VO2max could still reliably predict postoperative complications and deaths in lung cancer patients undergoing pneumonectomy and which values could be more reliably considered as the optimal threshold.
Methods : We retrospectively collected data of consecutive patients undergoing pneumonectomy for primary lung cancer at the European Oncological Institute (April 2019-April 2023). Routine preoperative assessment included cardiopulmonary exercise testing (CPET) and a lung perfusion scan. We evaluated the morbidity and mortality rates; associations between morbidity, mortality, VO2max, and ppoVO2max values were investigated through ANOVA or Fisher’s exact test as appropriate. Receiver operating characteristic (ROC) curves were applied to further explore the relation between VO2max, ppoVO2max values, and 90-day mortality.
Results : The cardiopulmonary morbidity rate was 32.2%; the 30-day and 90-day mortality rates were 2.2% and 6.7%. The PpoVO2max values were significantly lower in patients experiencing cardiopulmonary complications or deaths compared to the whole cohort, whereas VO2max, though showing a trend towards lower values, did not reach statistical significance. A VO2max value threshold of 15 mL/kg/min correlated significantly with 90-day mortality, while a ppoVO2max cut-off of 10 mL/kg/min was significantly associated with cardiopulmonary complications and 30-day and 90-day mortality rates. ROC curve analysis revealed ppoVO2max as a better predictor of 90-day mortality compared to VO2max.
Conclusions : CPET and a lung perfusion scan are two key elements for the preoperative evaluation of patients undergoing pneumonectomy, since it provides a holistic assessment of cardiopulmonary functionality. We recommend the routine calculation of ppoVO2max, particularly when adopting a 10 mL/kg/min threshold.

Unexplained breathlessness:integrating pathophysiological insights with clinical evaluation.

Baccelli A; Department of Respiratory Medicine, Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Giudice FL; Haji G; Davies RJ; K.Gin-Sing W; Howard LS;

Clinical medicine (London, England) [Clin Med (Lond)] 2025 Apr 09, pp. 100313.
Date of Electronic Publication: 2025 Apr 09.

Unexplained breathlessness is a challenging symptom encountered across diverse medical conditions. This review will briefly overview the interplay between central neural mechanisms and peripheral receptor activity leading to symptom perception. A holistic and multidisciplinary approach to unexplained breathlessness is crucial to assess and optimize known comorbidities, as well as investigate potential less common conditions associated with dyspnoea. Specific advanced testing modalities will be briefly discussed in the context of breathing pattern disorders, laryngeal hyperreactivity, disorders of the pulmonary vasculature, autonomic dysfunction, and cardiovascular diseases.

Neurophysiological mechanisms of exertional dyspnea in advanced pregnancy: a case study.

Phillips DB; School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Darko CA; James MD; Vincent SG; McCartney AM; Sreibers LK; Domnik NJ;Neder JA; O’Donnell DE;

Respiratory physiology & neurobiology [Respir Physiol Neurobiol] 2025 Apr 18, pp. 104434.
Date of Electronic Publication: 2025 Apr 18.

The neurophysiological mechanisms of exertional dyspnea in advanced pregnancy remain incompletely understood. This short case report describes the neurophysiological and sensory responses during standardized cardiopulmonary exercise testing (CPET) in one healthy adult female at three timepoints: a) 3 months pre-pregnancy, b) 35 weeks pregnant (third trimester [T3]), and, c) 1 year post-partum.
At rest and during exercise, detailed measurements of neurophysiological, gas-exchange and sensory parameters were completed. Compared to both pre-pregnancy and post-partum, ventilatory requirements, electrical activation of the diaphragm (EMGdi, index of inspiratory neural drive) and esophageal pressure swings were higher in T3 throughout exercise. Moreover, at a given work rate, perceived dyspnea was greater in T3 compared with pre-pregnancy and post-partum and increased in close association with heightened EMGdi throughout exercise. At peak exercise in T3, dyspnea/ventilation and EMGdi/ventilation ratios were greater, compared with pre-pregnancy and post-partum. Compared with pre-pregnancy, EMGdi and perceived dyspnea were greater post-partum near the limits of exercise tolerance, secondary to earlier onset of respiratory compensation-mediated increases in ventilation. In the current case, advanced pregnancy was associated with markedly elevated ratings of dyspnea and lower exercise capacity during a standardized clinical CPET. At submaximal intensities, the heightened dyspnea reflected the awareness of pregnancy-induced increases in ventilatory requirements, inspiratory neural drive, and respiratory muscle effort. At the limits of tolerance, heightened dyspnea and inspiratory neural drive reflected a complex combination of increase ventilatory requirements and mechanical constraints on tidal volume expansion. Compared with pre-pregnancy, residual activity-related dyspnea 1-year post-partum appears to reflect physical deconditioning.

Cardiopulmonary Exercise Testing With Forehead and Popliteal Oximetry in Evaluating Efficacy of Reverse Potts Shunt.

Mamillo, Keti; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, USA
Frantz, Robert P; Anderson, Jason H; Allison, Thomas G;

JACC. Case reports,2025 Apr 02

Reverse Potts shunt (rPS) is a surgical procedure that creates an anastomosis between the left pulmonary artery and descending aorta to decompress the right ventricle in suprasystemic pulmonary arterial hypertension (PAH). In this paper, we introduce a unique procedure combining cardiopulmonary exercise testing with forehead and popliteal oximetry to evaluate the efficacy of the rPS. Our study involved tests on 4 patients with PAH who had the shunt in place. We found that the level of oxygen saturation in the popliteal artery decreased during exercise and correlated with the rPS efficacy and the overall clinical outcome. In conclusion, we demonstrate a simple, noninvasive technique for evaluating patency and function of rPS in patients with suprasystemic PAH.

Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertension.

Baccelli, Andrea; Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Rinaldo, Rocco F; Haji, Gulammehdi; Davies, Rachel J;

The European respiratory journal,2025 Apr 10

  • Background: Current guidelines recommend a four-strata model based on World Health Organization functional class (WHO-FC), 6-min walk distance (6MWD), and serum levels of brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) for risk stratification in patients with pulmonary arterial hypertension (PAH) during follow-up. We explored the relevance of using cardiopulmonary exercise testing (CPET) as the exercise parameter in place of 6MWD at first reassessment after treatment initiation in PAH.
  • Methods: Incident treatment-naïve patients with idiopathic, heritable, drug/toxins-induced, and connective tissue disease-associated PAH between 2010 and 2022 were analysed. Correlations between CPET and haemodynamic and right ventricular (RV) function parameters were explored and those which were significant were carried forward to assess association with survival. Independent predictors were used to derive a four-strata CPET score.
  • Results: 262 patients were included. CPET parameters showed better correlations with haemodynamics and RV function than 6MWD. The CPET score included peak oxygen uptake (peak VO 2 ), the slope relating ventilation to carbon dioxide production (VE/VCO 2 slope), and peak oxygen pulse. The four-strata model based on WHO-FC, BNP, and CPET score predicted survival at the time of the first re-evaluation, with better accuracy than the model including 6MWD (c-index 0.81 versus 0.71). The CPET score on its own also performed well (c-index 0.82) with a greater spread between categories. Treatment-associated changes in peak VO 2 and oxygen pulse predicted survival, while changes in 6MWD did not.
  • Conclusions: A simplified four-strata CPET score either alone or included with BNP and WHO-FC accurately predicts survival at follow-up in PAH.